BridgeBio Pharma Property, Plant, and Equipment 2018-2024 | BBIO
BridgeBio Pharma property, plant, and equipment from 2018 to 2024. Property, plant, and equipment can be defined as the sum of all net property, plant & Equipment fields. Where companies do not report a break down of plant, property, & equipment, the value is entered in this field alone.
BridgeBio Pharma Annual Property, Plant, and Equipment
(Millions of US $) |
| 2023 |
$12 |
| 2022 |
$15 |
| 2021 |
$30 |
| 2020 |
$20 |
| 2019 |
$6 |
| 2018 |
$2 |
| 2017 |
$ |
BridgeBio Pharma Quarterly Property, Plant, and Equipment
(Millions of US $) |
| 2024-06-30 |
$10 |
| 2024-03-31 |
$11 |
| 2023-12-31 |
$12 |
| 2023-09-30 |
$12 |
| 2023-06-30 |
$13 |
| 2023-03-31 |
$14 |
| 2022-12-31 |
$15 |
| 2022-09-30 |
$16 |
| 2022-06-30 |
$17 |
| 2022-03-31 |
$17 |
| 2021-12-31 |
$30 |
| 2021-09-30 |
$28 |
| 2021-06-30 |
$26 |
| 2021-03-31 |
$23 |
| 2020-12-31 |
$20 |
| 2020-09-30 |
$16 |
| 2020-06-30 |
$16 |
| 2020-03-31 |
$16 |
| 2019-12-31 |
$6 |
| 2019-09-30 |
$3 |
| 2019-06-30 |
|
| 2019-03-31 |
|
| 2018-12-31 |
|
| 2018-09-30 |
|
| 2017-12-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$4.629B |
$0.009B |
|
BridgeBio Pharma Inc. discovers, develops and innovates drugs for genetic diseases. The Company's product platform consists of Mendelian, Oncology and Gene therapy. Its product pipeline includes BBP-265, BBP-831, BBP-631 and BBP-454 which are in clinical stage. BridgeBio Pharma Inc. is based in CA, United States.
|
